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Conjunctival malignant melanoma is an infrequent neo-
plasm of the ocular surface that usually occurs in the back-
ground of primary acquired melanosis (PAM) with atypia in
persons of Caucasian ethnicity. Classically, it presents as a
darkly pigmented mass of variable duration (often short) in
the interpalpebral region of the bulbar surface that would
cause littlediagnosticdifficulty for theophthalmologist.On tis-
sue examination, most ophthalmic pathologists (and general
anatomical pathologists aswell)would recognize theexpansile
nodule of epithelioid appearing pigmented malignant mela-
nocytes in the substantia propria of the conjunctiva character-
istic of malignant melanoma. However, malignant melanomas
of other body sites are capable of protean presentations and
pathology and the eye is no stranger to this territory.
This paper describes a rare signet ring cell variant of
malignant melanoma of the conjunctiva arising in PAM,
previously un-reported in the North American and European
literature. A discussion of the diagnostic and therapeutic
considerations when faced with ocular surface conditions
simulating malignant melanoma will follow.Peer review under responsibility
of Saudi Ophthalmological Society,
King Saud University
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A Caucasian woman in her 6th decade of life presented
with a pigmented lesion on the medial inferior bulbar con-
junctiva of the left eye of unknown duration. The lesion was
biopsied in mid-2007 at a peripheral hospital and due to dif-
ficulty with the pathologic interpretation it was referred for
consultation. Ocular history was unremarkable. The remain-
der of the ocular examination was also unremarkable.
Histopathologic examination of the conjunctival lesion
revealed a well-circumscribed nodule in the substantia
propria (Fig. 1). In the conjunctival epithelium was a lentigi-
nous proliferation of atypical, variably pigmented melano-
cytes along the basal layer that in places involved a little
over half of the epithelial thickness (Fig. 2), consistent with pri-
mary acquired melanosis (PAM) with mild to moderate atypia.
The nodule in the substantia propria consisted of a prolifera-
tion of signet ring type cells with hyperchromatic nuclei (some
containing intranuclear vacuoles) displaced to the periphery
of the cell by prominent amphophilic cytoplasm.
Immunohistochemical staining of the nodule revealed
strong positivity for cytoplasmic vimentin, PanMel (Fig. 3)j Production and hosting by ElsevierAccess this article online: www.saudiophthaljournal.comwww.sciencedirect.com
uary 2012.
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Figure 1. High power view of the nodule in the substantia propria
demonstrating the signet ring morphology (eccentric hyperchromatic
nuclei and prominent amphophilic cytoplasm). Note the occasional
but infrequent cytoplasmic pigment. (hematoxylin and eosin stain,
400).
Figure 3. Immunohistochemical stain PanMel highlighting the strong
cytoplasmic positivity of the signet ring cells for the combined melano-
cytic markers in the PanMel stain (400).
Figure 4. Immunohistochemical stain PanMel highlighting the extent of
PAM in the conjunctival epithelium away from the tumor (200).
152 D.H. Albreiki et al.and HMB-45; moderate positivity for S-100 protein; and neg-
ativity for mucin and cytokeratins. The PanMel stain also high-
lighted the extent of the PAM in the epithelium away from
the tumor (Fig. 4).
Although the submitting pathologist favored a diagnosis
of metastatic signet ring cell adenocarcinoma, a final diagno-
sis of signet ring cell melanoma of the conjunctiva in a back-
ground of primary acquired melanosis with mild to moderate
atypia was rendered. Further evaluation of the patient re-
vealed no evidence of other primary melanomas or metasta-
sis. No further treatment was given.
The patient presented with recurrence of a pigmented le-
sion in the same site 8 months later, which was excised and
treated with cryotherapy to the bed of the lesion. Histo-
pathologic evaluation revealed the same signet ring cell
morphology as shown in the initial biopsy. In consultation
with the patient, oncologist and surgeon, it was decided
to follow her clinically without resorting to more aggressive
therapy.Figure 2. Immunohistochemical stain PanMel highlighting the extent of
(PAM) in the conjunctival epithelium overlying the tumor (200).Discussion
Signet ring cell melanoma is a very rare condition. It has
been reported in skin,1–6 but usually as a metastatic lesion
from a primary melanoma. An extensive search of the North
American and European databases Medline and EmBase be-
tween 1946 and 2011 revealed that this condition has never
been described in the conjunctiva.
Given that this lesion occurred in a background of primary
acquired melanosis with moderate atypia, we feel this lesion
is a primary malignant melanoma of the conjunctiva. This is
supported as well by the evidence that this patient was
screened and no other primary source was found. The initial
difficulty in the diagnosis of this lesion was the unusual
histomorphology, which initially led to a consideration of
metastatic signet ring cell carcinoma. Immunohistochemical
staining was vital in establishing the diagnosis. Pathologists
should add this to the differential diagnosis of metastatic
signet ring cell neoplasia to the conjunctiva.
This case serves as a useful introduction to a review of the
lesions of the conjunctiva that may mimic conjunctival
Table 1. Adapted from Ref. 8.
Types of non-melanocytic ocular pigmentation
Scleral disease
Blue sclera
Staphyloma
Scleromalacia
Senile hyaline plaque
Metabolic disorders
Ochronosis
Gaucher’s disease
Jaundice
Pigmented deposits
Epinephrine
Argyria
Mascara
Quinolone
Iron
Hemosiderin
Conjunctival malignant melanoma 153melanomas. Neoplastic lesions of the conjunctiva can be clas-
sified in many ways; a useful paradigm involves dividing them
into pigmented (melanotic) and non-pigmented (amelanotic)
lesions. Differentiation between these conjunctival lesions
can be challenging, hence the importance of an accurate
diagnosis for the purpose of appropriate management and
prognosis. Clinical examination with slit lamp biomicroscopy
may be enough to establish a diagnosis in most of the cases
with classical anterior segment features; nevertheless, the vi-
tal role of histopathology cannot be over emphasized for a
definite diagnosis in cases that appear unusual.
It is occasionally difficult to decide when a biopsy of a con-
junctival lesion is necessary. Proper history regarding lesion
characteristics (appearance, duration, accompanying symp-
toms), medical and family history, ethnic background, and
use of medications are extremely important. A proper clinical
examination with slit lamp biomicroscopy that includes the
size, color, focality, laterality, borders, elevation, feeder ves-
sels, and location of the lesion with drawings for documenta-
tion is essential. In addition, a color photograph is useful in
detecting progression of these lesions that may not be easily
monitored with a simple drawing. When in doubt, a tissue
biopsy is required for a definite diagnosis. A diagnostic biopsy
is not usually necessary in cases of smaller tumors (<4 clock
hours of limbal tumor or <15 mm basal dimension) that ap-
pear benign. If a small lesion appears suspicious, an excisional
biopsy may suffice. However, if a larger lesion requires a
biopsy, then an initial incisional biopsy may be appropriate
and depending on the histopathologic diagnosis, more exten-
sive surgery can be performed accordingly.7
Pigmented lesions of the conjunctiva may be melanocytic
or non-melanocytic (see Table 1 for pigmented non-
melanocytic lesions 8 – not discussed in this paper).
Melanocytic lesions of the conjunctiva can be classified into
nevi (congenital and acquired), melanosis (congenital and
acquired), and malignant melanoma.9
In the above case, the differential diagnosis included pig-
mented lesions such as a conjunctival nevus and pigmented
squamous carcinoma. If the lesion had been amelanotic,
non-pigmented conjunctival lesions that may mimic amela-
notic conjunctival melanomas, such as papillomas, pterygia,
lymphoid hyperplasia, sebaceous gland carcinoma, and squa-
mous carcinoma 10 would be considered.Pigmented lesions
Malignant melanoma of the conjunctiva
Malignant melanoma of the conjunctiva presents as a
raised, pigmented, or infrequently, a non-pigmented lesion.
It may arise de novo; from a pre-existing nevus; but most com-
monly it arises from PAM.9 It represents a proliferation of
atypical melanocytes that originates at some point in the con-
junctival epithelium and by definition invades into the sub-
stantia propria (as opposed to malignant melanoma in situ,
a non-invasive proliferation confined to the epithelium).
It can occur in all age groups, but most commonly in mid-
dle-aged adults and more commonly in fair-skinned individu-
als. It can occur in any part of the conjunctiva, but prefers the
medial and temporal aspects.7 Malignant melanomas of the
conjunctiva are quite rare (<2% of ocular malignancies), but
are potentially lethal. 7 It can spread through lymphaticsand bloodstream or it can undergo direct extension to the
globe and orbit. It most commonly metastasizes to the lung,
liver, brain and bone.10 Ulceration and tumors greater than
2.0 mm in thickness are associated with a higher risk of dis-
tant metastasis.11 The amelanotic form of conjunctival mela-
noma is particularly aggressive and associated with a poor
prognosis and risk of metastatic disease.12,13
Histopathologically, melanoma cells most often are epi-
thelioid (like epithelial cells) in cytomorphology and grow as
irregular nests; or continuous or discontinuous single cells,
that extend through all the layers of the conjunctival epithe-
lium and into the substantia propria. An indication of epithe-
lial malignancy is the irregular and scattered ascent of the
atypical melanocytes to the surface of the conjunctival epi-
thelium (so called pagetoid spread). These cells have large
nuclei with chromatin clumping at the periphery of the nucle-
ar membrane and distinct, usually large, eosinophilic nucleoli.
Immunohistochemical staining with the melanocytic specific
antibodies Melan-A (MART-1) and microphthalmia transcrip-
tion factor (Mitf) are the most useful stains for identifying the
proliferation as melanocytic, followed by the melanoma spe-
cific HMB-45 antibody.10 Although useful in other tissues, the
S-100 antibody stain is not as sensitive and specific in con-
junctival proliferations and its lack of significant staining
may be misleading.
Ultrasound biomicroscopy (UBM) may serve as an addi-
tional diagnostic tool to estimate the tumor thickness prior
to surgical resection of a conjunctival melanoma. Although
infrequent, extra-scleral extension of a ciliary body melanoma
can simulate a conjunctival melanoma and here UBM would
prove very useful to confirm the location of the tumor.10
Management of conjunctival melanomas includes surgical
resection with a wide margin excision (>3 mm), cryotherapy,
and may also include topical mitomycin C (MMC) and/or alco-
hol epitheliectomy,7 and topical interferon alfa-2b.14 If more
extensive with orbital invasion, exenteration may be re-
quired. It is extremely important to examine the patient for
metastasis in regional lymph nodes (pre-auricular and sub-
mandibular, as well as their draining basins), and consult
the oncology service for a systemic metastatic workup.10
The role of sentinel lymph node biopsy in conjunctival mela-
noma is unclear and not a standard practice in many centers
and therefore will not be discussed here.
154 D.H. Albreiki et al.Congenital racial melanosis
Racialmelanosis is a commoncongenital, bilateral condition
characterized by flat pigmentation of the conjunctiva usually
found in darkly pigmented individuals. Most common parts
of the conjunctiva affected are the limbus (typically 3–4 mm
from the limbus), and bulbar surfaces. Also not uncommonly
they may be more intense around an Axenfeld loop or around
an anterior ciliary vessel. The pigmentation is freely mobile
over the sclera as the pigmentation is localized to the epithelial
layer of the conjunctiva.9 It has essentially no risk of malignant
transformation, although it can be mistaken for a pre-malig-
nant condition (primary acquired melanosis – see below).7Conjunctival nevus
This is the most common melanocytic lesion of the con-
junctiva. Most arise in the first decade or young adulthood,
but can be present at all ages including the elderly; they
are more common in Caucasians than other races and there
is no gender predilection.15
The most common regions of the conjunctiva affected are
juxta-limbal, followed by caruncle, and finally, plica semilun-
aris. Clinically they can vary in size, ranging from very small
to occupying over half the conjunctiva. They may contain
cysts, and range in pigmentation from completely amelanotic
to dark brown to black.9 They are usually freely mobile over
the surface of the globe (except at the limbus), and this par-
ticular clinical feature is of importance because if a potential
nevus is immobile (adherent to the globe), an underlying
malignant melanoma should be suspected.7
Nevi are classified histopathologically into junctional (ba-
sal epithelial in location), subepithelial (entirely within the
substantia propria), compound (a combination of junctional
and subepithelial), and other less common subtypes such as
blue nevi and combined nevi (nevi with both a compound
and blue component). These benign neoplasms are com-
posed of nests of nevomelanocytes which are polyhedral in
shape and somewhat larger than the benign dendritic mela-
nocytes which are indigenous to the epithelium. Around pub-
erty, it is important to recognize that these lesions may
proliferate (enlarge), secrete material (causing any cysts to
enlarge) and change in color (usually darken) making them
more noticeable. In the juvenile age group, they can display
worrisome, yet benign, architectural and cytological features
on pathological examination.15
Clinical examination (including slit lamp biomicroscopy),
and color photographs are recommended for follow-up of
these patients.9 If the lesion changes (such as documented
growth, color change, ulceration), especially in adults, a
biopsy is indicated for a definite diagnosis. An excisional
biopsy is best, using the no touch technique, also removing
a thin lamella of the sclera, and applying cryotherapy to the
margins.7
There is less than 1% chance of a nevus transforming into a
malignancy9; however, if it happens, there is a significant
mortality rate (13% at 10 years).7Ocular melanocytosis
This is a congenital lesion characterized by an increase in
the number, size, and pigmentation of spindled melanocytesin the episclera, uveal tract and occasionally ipsilateral orbit,
meninges, and soft palate.7 It is more common in Asians and
darkly pigmented individuals. When there is associated skin
pigmentation, usually in the trigeminal and/or maxillary nerve
distribution, it is referred to as the ‘‘nevus of Ota’’. Although
the anterior segment involvement is not a conjunctival lesion,
it is easily mistaken for one. Clinically, it consists of a flat, gray
brown pigmentation scattered over the sclera, with or
without a diffuse choroidal nevus.9 Histopathologically, the
spindled melanocytic proliferation constitutes a blue nevus
existing in the deep substantia propria/epislceral soft tissues
(in contrast to a blue nevus of the conjunctiva which is pre-
dominately localized to the superficial substantia propria). It
is important to remember the association between this lesion
and uveal melanoma (1 in 400 lifetime risk among Caucasians
with this condition), as well as the occurrence less commonly
of orbital and meningeal melanomas in patients with this
lesion.7 Another important association is the risk of ipsilateral
glaucoma in 10% of the cases.9Primary acquired melanosis (PAM)
This is an acquired, almost always unilateral, brown or tan
colored flat patchy lesion of the conjunctiva that characteris-
tically has a tendency to wax and wane over the lifetime of
the individual. It affects middle-aged individuals typically of
Caucasian ethnicity.9 It differs from a nevus historically as it
is acquired in middle age, and clinically lacks a cystic compo-
nent. It differs from ocular melanocytosis as the pigmentation
is acquired, located within the conjunctiva, and is brown
rather than gray. As for racial melanosis, PAM is different in
terms of demographics as it is usually found in fair-skinned
individuals and is unilateral.7
Primary acquired melanosis is classified on the basis of
histopathology into PAM without atypia (with no malignant
potential), and PAM with atypia, which has a significant
malignant potential (although in the past it was suggested
that up to 45% evolved into melanoma, recent data suggest
that this evolution is significantly lower at 8% at 5 years).16
The criteria defining atypia in PAM include architectural
abnormalities (discontinuous lentiginous spread of atypical
melanocytes; extension above the basal layer of the epithe-
lium with intraepithelial nesting; full thickness epithelial
disposition and pagetoid ascent), cytological features (epi-
thelioid morphology and nuclear hyperchromasia and
enlargement) and now should be supplemented with immu-
nohistochemical evidence of both the extent of the melano-
cytic proliferation (with the antibodies Melan-A (MART-1)
and/or microphthalmia transcription factor) and increased
cell proliferation (with increased Ki-67 (MIB-1) activity).
The management of PAM depends on the extent of
involvement and the association with melanoma. It may
range from observation of a small lesion (<3 clock hours) to
an excisional biopsy with a wide margin along with cryother-
apy. If the lesion is too large for complete excision or involves
the fornices, selected incisional biopsies of any features that
lead to suspicion of a malignant melanoma (nodular thicken-
ing in a previously flat area of pigmentation, increased vascu-
larity, fixation of the conjunctiva to the underlying sclera, and
ulceration), along with map biopsies of all four quadrants
should be performed. If only epithelial disease is found,
Conjunctival malignant melanoma 155topical cryotherapy and or MMC are indicated. Management
may also include radiotherapy.7
Table 2 summarizes the key differential diagnostic points
of the pigmented melanocytic conjunctival lesions.7
Pigmented squamous cell carcinoma (PSCC) of the
conjunctiva
This is a rare condition, with only a few reported cases in
the literature.17–19 It is defined as squamous cell carcinoma
of the conjunctiva with cytoplasmic pigment in the tumor, ex-
actly the same histopathologically as conventional squamous
cell carcinoma (SCC). Clinically it is almost impossible to dis-
tinguish this from conjunctival melanoma, which is more com-
mon and more lethal. Histopathology of the reported cases
refers to both squamous cell carcinoma in situ (confined to
the epithelium) and less commonly invasive squamous cell
carcinoma in the substantia propria.17 Pigmentation is
thought to arise from a neighboring melanocytic lesion, as
most of the cases reported had racial melanosis, nevus, len-
tigo or pigmented solar keratosis juxtaposed to the tumor.17
Immunohistochemically, the neoplastic cells are strongly
cytokeratin positive and are negative for melanocytic mark-
ers. Conjunctival PSCC appears to be slow growing, with lit-
tle tendency for scleral invasion or distant metastasis.17–19
Management of this lesion is the same as for non-pigmented
squamous cell carcinoma as discussed below.Non-pigmented lesions
Not all conjunctival melanomas are pigmented; melano-
mas with little or no pigment can look like squamous and
sebaceous gland carcinomas, papillomas, lymphoid hyper-
plasia, and even pterygia.10
Sebaceous gland carcinoma of the conjunctiva
Sebaceous carcinoma is a very rare malignant tumor with
an incidence of 3.2% among malignant tumors and 0.8% of
all eyelid tumors.20 It usually arises from the tarsal meibomian
glands, or less commonly from Zeis glands of the eyelashes,
or sebaceous glands of the caruncle and usually extends into
the adjacent conjunctiva. It is extremely rare for this type ofTable 2. Adapted from Ref. 7.
Condition Anatomical location Color Depth Borde
Nevus Interpalpebral
limbus
Brown/
yellow
Stroma Well d
Racial melanosis Limbus, bulbar,
palpebral
conjunctiva
Brown Epithelium Ill defi
Ocular
melanocytosis
Bulbar conjunctiva Gray Episclera Ill defi
Primary acquired
melanosis (PAM)
Anywhere, but
usually bulbar
conjunctiva
Brown Epithelium Ill defi
Malignant
melanoma
Anywhere Brown
or pink
Stroma Well dtumor to arise primarily from the conjunctiva. Only a few re-
ported cases in the literature confirm this fact.20 Histopatho-
logically, it is characterized by atypical basaloid appearing
cells with foamy cytoplasm demonstrating pagetoid involve-
ment of the epithelium and extending into the substantia
propria as either a nested or diffused sheet-like infiltration.
It has a marked tendency to metastasize early and is associ-
ated with a significant mortality.20Lymphoproliferative disorders
These disorders can occur in the conjunctiva as isolated
masses (primary disease) or may reflect a systemic condition
(secondary disease). Typically, they present as a diffuse pink
mass, slightly elevated, and most commonly located in the
stroma of the forniceal conjunctiva. The typical clinical
appearance of the pinkish hue is referred to as a ‘‘salmon
patch’’. Only biopsy can determine the benign or malignant
nature of this condition. Sheets of lymphocytes are found
histopathologically, and are classified as reactive or atypical
lymphoid hyperplasia, or malignant lymphoma. Most of the
lymphomas are low grade B cell Non-Hodgkin’s lymphomas
of the MALT (mucosa associated lymphoid tissue) subtype.
Management includes chemotherapy and radiation therapy,
depending on whether it is primary (confined to the conjunc-
tiva) or secondary (associated with systemic lymphoma).7Conjunctival papilloma
Squamous papilloma is a benign tumor, which is often
associated with human papillomavirus (subtypes 6, 11, 16,
and 18) infection of the conjunctiva. This lesion can occur in
any age group, and is believed to be transmitted from
mother’s vagina to child’s conjunctiva through the birth
canal.7 Clinically, a papilloma appears as a pink mass with
delicate, vascular fronds that may be pedunculated, usually
located at the caruncle or in the inferior fornix, or sessile,
usually located at the limbus. It can range from a small lesion
to a quite extensive one covering the entire interpalpebral
conjunctival and/or corneal surface simulating squamous cell
carcinoma. Histopathologically it contains numerous vascu-
larized papillary structures lined by acanthotic epithelium.
Management can include observation (as some undergors Laterality Other features Progression
efined Unilateral Cysts <1% progress to
conjunctival melanoma
ned Bilateral Flat, no cysts Negligible
progression to
malignant melanoma
ned Unilateral
more so
than
bilateral
Congenital, usually
2 mm from the
limbus, often with
periocular skin
pigmentation
<1% progress to uveal
melanoma (except in
Caucasians: 1 in 400
risk of progression)
ned Unilateral Flat no cysts Progress to
conjunctival melanoma
in cases that show
atypia (see text above)
efined Unilateral Vascular nodules,
feeder vessels, maybe
non-pigmented
32% develop distant
metastasis by 15 years
156 D.H. Albreiki et al.spontaneous resolution), surgical excision, cryotherapy, topi-
cal interferon and mitomycin C, and oral cimetidine.7
Ocular surface squamous neoplasia (OSSN)
OSSN is a fleshy, sessile lesion that may be flat or slightly
elevated, located most commonly at the limbus in the inter-
palpebral fissure. Secondary hyperkeratosis may lead to the
appearance of leukoplakia. Histopathologically, the lesion
shows partial thickness replacement of the surface epithelium
with abnormal epithelial cells that lack normal maturation – a
process referred to as dysplasia. Grading of dysplasia de-
pends on the thickness of the involved epithelium ranging
from mild (only 1/3 of the thickness) to full thickness of the
epithelium, which is variably referred to as severe dysplasia
or carcinoma in situ (CIS).7,16 Carcinoma in situ has a much
higher risk of invasive carcinoma than the lower grades of
dysplasia.
Squamous cell carcinoma of the conjunctiva (SCC)
Conjunctival SCC typically develops in either the limbal or
bulbar conjunctiva as a fleshy pink, gelatinous, amelanotic,
sometimes plaque-like mass. Pathologically, it represents an
extension of in situ squamous carcinoma that has invaded
through the epithelial basement membrane into the substan-
tia propria where it gains access to the blood vessels and
lymphatics with the ability for metastasizing, which fortu-
nately is uncommon. Important to note is the medical history
of the patient. Patients who are HIV positive or are immuno-
suppressed are more likely to develop this type of tumor and
notably at a younger age (as young as 20–30 years, unlike the
50–70 years in typical SCC). And if so, are also at a higher risk
for metastasis. Management includes partial lamellar sclero-
conjunctivectomy with wide margins for the conjunctival
component (and alcohol epitheliectomy for a corneal compo-
nent if present) followed by cryotherapy. A thin lamella of
underlying sclera should be removed where the tumor is
adherent to the globe. Treatment may also include topical
MMC, 5-fluorouracil, or interferon particularly in recurrent
cases.7
Conjunctival metastases
Finally, metastatic tumor to the conjunctiva, although a
rare occurrence, should not be forgotten. Primary sites in-
clude breast, lung, cutaneous melanoma and larynx and
may present as flesh colored and non-pigmented masses.21
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